BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sohail MA, Hashmi AZ, Hakim W, Watanabe A, Zipprich A, Groszmann RJ, Dranoff JA, Torok NJ, Mehal WZ. Adenosine induces loss of actin stress fibers and inhibits contraction in hepatic stellate cells via Rho inhibition. Hepatology. 2009;49:185-194. [PMID: 18844235 DOI: 10.1002/hep.22589] [Cited by in Crossref: 60] [Cited by in F6Publishing: 57] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Dhar A, Sadiq F, Anstee QM, Levene AP, Goldin RD, Thursz MR. Thrombin and factor Xa link the coagulation system with liver fibrosis. BMC Gastroenterol. 2018;18:60. [PMID: 29739329 DOI: 10.1186/s12876-018-0789-8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
2 Gao X, Qian J, Zheng S, Changyi Y, Zhang J, Ju S, Zhu J, Li C. Overcoming the blood-brain barrier for delivering drugs into the brain by using adenosine receptor nanoagonist. ACS Nano 2014;8:3678-89. [PMID: 24673594 DOI: 10.1021/nn5003375] [Cited by in Crossref: 97] [Cited by in F6Publishing: 89] [Article Influence: 13.9] [Reference Citation Analysis]
3 Lei Y, Wang QL, Shen L, Tao YY, Liu CH. MicroRNA-101 suppresses liver fibrosis by downregulating PI3K/Akt/mTOR signaling pathway. Clin Res Hepatol Gastroenterol. 2019;pii:S2210-7401(19)30041-5. [PMID: 30857885 DOI: 10.1016/j.clinre.2019.02.003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
4 Shimada S, Wakayama K, Fukai M, Shimamura T, Ishikawa T, Fukumori D, Shibata M, Yamashita K, Kimura T, Todo S. Hydrogen Gas Ameliorates Hepatic Reperfusion Injury After Prolonged Cold Preservation in Isolated Perfused Rat Liver. Artif Organs. 2016; Epub ahead of print. [PMID: 27140066 DOI: 10.1111/aor.12710] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 3.4] [Reference Citation Analysis]
5 Higashi T, Friedman SL, Hoshida Y. Hepatic stellate cells as key target in liver fibrosis. Adv Drug Deliv Rev. 2017;121:27-42. [PMID: 28506744 DOI: 10.1016/j.addr.2017.05.007] [Cited by in Crossref: 359] [Cited by in F6Publishing: 350] [Article Influence: 89.8] [Reference Citation Analysis]
6 Li S, Wang L, Yan X, Wang Q, Tao Y, Li J, Peng Y, Liu P, Liu C. Salvianolic Acid B Attenuates Rat Hepatic Fibrosis via Downregulating Angiotensin II Signaling. Evid Based Complement Alternat Med 2012;2012:160726. [PMID: 23243430 DOI: 10.1155/2012/160726] [Cited by in Crossref: 24] [Cited by in F6Publishing: 31] [Article Influence: 2.7] [Reference Citation Analysis]
7 Ouyang X, Ghani A, Malik A, Wilder T, Colegio OR, Flavell RA, Cronstein BN, Mehal WZ. Adenosine is required for sustained inflammasome activation via the A₂A receptor and the HIF-1α pathway. Nat Commun 2013;4:2909. [PMID: 24352507 DOI: 10.1038/ncomms3909] [Cited by in Crossref: 65] [Cited by in F6Publishing: 66] [Article Influence: 9.3] [Reference Citation Analysis]
8 Xu H, Zhou Y, Lu C, Ping J, Xu LM. Salvianolic acid B lowers portal pressure in cirrhotic rats and attenuates contraction of rat hepatic stellate cells by inhibiting RhoA signaling pathway. Lab Invest. 2012;92:1738-1748. [PMID: 22986787 DOI: 10.1038/labinvest.2012.113] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.9] [Reference Citation Analysis]
9 Li J, Kuruba R, Wilson A, Gao X, Zhang Y, Li S. Inhibition of endothelin-1-mediated contraction of hepatic stellate cells by FXR ligand. PLoS One. 2010;5:e13955. [PMID: 21085652 DOI: 10.1371/journal.pone.0013955] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 3.3] [Reference Citation Analysis]
10 Ahsan MK, Mehal WZ. Activation of adenosine receptor A2A increases HSC proliferation and inhibits death and senescence by down-regulation of p53 and Rb. Front Pharmacol. 2014;5:69. [PMID: 24782773 DOI: 10.3389/fphar.2014.00069] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
11 Baldanzi G, Alchera E, Imarisio C, Gaggianesi M, Dal Ponte C, Nitti M, Domenicotti C, van Blitterswijk WJ, Albano E, Graziani A, Carini R. Negative regulation of diacylglycerol kinase theta mediates adenosine-dependent hepatocyte preconditioning. Cell Death Differ 2010;17:1059-68. [PMID: 20057501 DOI: 10.1038/cdd.2009.210] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]
12 Kim DG, Bynoe MS. A2A Adenosine Receptor Regulates the Human Blood-Brain Barrier Permeability. Mol Neurobiol 2015;52:664-78. [PMID: 25262373 DOI: 10.1007/s12035-014-8879-2] [Cited by in Crossref: 60] [Cited by in F6Publishing: 58] [Article Influence: 8.6] [Reference Citation Analysis]
13 Duval F, Moreno-Cuevas JE, González-Garza MT, Rodríguez-Montalvo C, Cruz-Vega DE. Liver fibrosis and protection mechanisms action of medicinal plants targeting apoptosis of hepatocytes and hepatic stellate cells. Adv Pharmacol Sci. 2014;2014:373295. [PMID: 25505905 DOI: 10.1155/2014/373295] [Cited by in Crossref: 10] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
14 Wang H, Guan W, Yang W, Wang Q, Zhao H, Yang F, Lv X, Li J. Caffeine inhibits the activation of hepatic stellate cells induced by acetaldehyde via adenosine A2A receptor mediated by the cAMP/PKA/SRC/ERK1/2/P38 MAPK signal pathway. PLoS One. 2014;9:e92482. [PMID: 24682220 DOI: 10.1371/journal.pone.0092482] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 5.4] [Reference Citation Analysis]
15 Friedman SL. Hepatic Fibrosis. In: Schiff ER, Maddrey WC, Sorrell MF, editors. Schiff's Diseases of the Liver. Oxford: Wiley-Blackwell; 2011. pp. 295-315. [DOI: 10.1002/9781119950509.ch12] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
16 Chan ESL, Cronstein BN. Adenosine in fibrosis. Modern Rheumatology 2014;20:114-22. [DOI: 10.3109/s10165-009-0251-4] [Cited by in Crossref: 22] [Cited by in F6Publishing: 11] [Article Influence: 3.1] [Reference Citation Analysis]
17 Wei L, Yang J, Wang M, Xu SN, Liang HM, Zhou Q. Sodium ferulate lowers portal pressure in rats with secondary biliary cirrhosis through the RhoA/Rho-kinase signaling pathway: a preliminary study. Int J Mol Med. 2014;34:1257-1267. [PMID: 25174394 DOI: 10.3892/ijmm.2014.1905] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
18 Flores-Muñoz C, Maripillán J, Vásquez-Navarrete J, Novoa-Molina J, Ceriani R, Sánchez HA, Abbott AC, Weinstein-Oppenheimer C, Brown DI, Cárdenas AM, García IE, Martínez AD. Restraint of Human Skin Fibroblast Motility, Migration, and Cell Surface Actin Dynamics, by Pannexin 1 and P2X7 Receptor Signaling. Int J Mol Sci 2021;22:1069. [PMID: 33499026 DOI: 10.3390/ijms22031069] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Dranoff JA, Feld JJ, Lavoie ÉG, Fausther M. How does coffee prevent liver fibrosis? biological plausibility for recent epidemiological observations. Hepatology 2014;60:464-7. [DOI: 10.1002/hep.27032] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
20 Feld JJ, Lavoie ÉG, Fausther M, Dranoff JA. I drink for my liver, Doc: emerging evidence that coffee prevents cirrhosis. F1000Res 2015;4:95. [PMID: 25977756 DOI: 10.12688/f1000research.6368.2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
21 Vollmar B, Menger MD. The hepatic microcirculation: mechanistic contributions and therapeutic targets in liver injury and repair. Physiol Rev. 2009;89:1269-1339. [PMID: 19789382 DOI: 10.1152/physrev.00027.2008] [Cited by in Crossref: 287] [Cited by in F6Publishing: 286] [Article Influence: 23.9] [Reference Citation Analysis]
22 Watanabe A, Sohail MA, Gautam S, Gomes DA, Mehal WZ. Adenine induces differentiation of rat hepatic stellate cells. Dig Dis Sci 2012;57:2371-8. [PMID: 22573344 DOI: 10.1007/s10620-012-2183-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
23 Cappellari AR, Vasques GJ, Bavaresco L, Braganhol E, Battastini AMO. Involvement of ecto-5′-nucleotidase/CD73 in U138MG glioma cell adhesion. Mol Cell Biochem 2012;359:315-22. [DOI: 10.1007/s11010-011-1025-9] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 3.2] [Reference Citation Analysis]
24 Fausther M, Sheung N, Saiman Y, Bansal MB, Dranoff JA. Activated hepatic stellate cells upregulate transcription of ecto-5'-nucleotidase/CD73 via specific SP1 and SMAD promoter elements. Am J Physiol Gastrointest Liver Physiol 2012;303:G904-14. [PMID: 22899823 DOI: 10.1152/ajpgi.00015.2012] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 4.3] [Reference Citation Analysis]
25 Cronstein BN. Adenosine receptors and fibrosis: a translational review. F1000 Biol Rep 2011;3:21. [PMID: 22003368 DOI: 10.3410/B3-21] [Cited by in Crossref: 43] [Cited by in F6Publishing: 23] [Article Influence: 4.3] [Reference Citation Analysis]
26 Kuroda S, Tashiro H, Kimura Y, Hirata K, Tsutada M, Mikuriya Y, Kobayashi T, Amano H, Tanaka Y, Ohdan H. Rho-kinase inhibitor targeting the liver prevents ischemia/reperfusion injury in the steatotic liver without major systemic adversity in rats: Rho-Kinase Inhibition in Hepatic Stellate Cells. Liver Transpl 2015;21:123-31. [DOI: 10.1002/lt.24020] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
27 Bynoe MS, Viret C, Yan A, Kim DG. Adenosine receptor signaling: a key to opening the blood-brain door. Fluids Barriers CNS 2015;12:20. [PMID: 26330053 DOI: 10.1186/s12987-015-0017-7] [Cited by in Crossref: 61] [Cited by in F6Publishing: 60] [Article Influence: 10.2] [Reference Citation Analysis]
28 Cheng QN, Yang X, Wu JF, Ai WB, Ni YR. Interaction of non‑parenchymal hepatocytes in the process of hepatic fibrosis (Review). Mol Med Rep 2021;23:364. [PMID: 33760176 DOI: 10.3892/mmr.2021.12003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Klein S, Klösel J, Schierwagen R, Körner C, Granzow M, Huss S, Mazar IG, Weber S, van den Ven PF, Pieper-Fürst U, Fürst DO, Nattermann J, Lammert F, Sauerbruch T, Trebicka J. Atorvastatin inhibits proliferation and apoptosis, but induces senescence in hepatic myofibroblasts and thereby attenuates hepatic fibrosis in rats. Lab Invest 2012;92:1440-50. [PMID: 22890553 DOI: 10.1038/labinvest.2012.106] [Cited by in Crossref: 65] [Cited by in F6Publishing: 63] [Article Influence: 7.2] [Reference Citation Analysis]
30 Ji H, Meng Y, Zhang X, Luo W, Wu P, Xiao B, Zhang Z, Li X. Aldosterone induction of hepatic stellate cell contraction through activation of RhoA/ROCK-2 signaling pathway. Regul Pept. 2011;169:13-20. [PMID: 21545816 DOI: 10.1016/j.regpep.2011.04.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
31 Chan ES, Cronstein BN. Adenosine in fibrosis. Mod Rheumatol 2010;20:114-22. [PMID: 19949965 DOI: 10.1007/s10165-009-0251-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 19] [Article Influence: 0.5] [Reference Citation Analysis]
32 Zhang F, Kong D, Chen L, Zhang X, Lian N, Zhu X, Lu Y, Zheng S. Peroxisome proliferator-activated receptor-γ interrupts angiogenic signal transduction by transrepression of platelet-derived growth factor-β receptor in hepatic stellate cells. J Cell Sci. 2014;127:305-314. [PMID: 24259663 DOI: 10.1242/jcs.128306] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
33 Mehal W, Imaeda A. Cell death and fibrogenesis. Semin Liver Dis. 2010;30:226-231. [PMID: 20665375 DOI: 10.1055/s-0030-1255352] [Cited by in Crossref: 41] [Cited by in F6Publishing: 45] [Article Influence: 3.7] [Reference Citation Analysis]
34 Puche JE, Saiman Y, Friedman SL. Hepatic stellate cells and liver fibrosis. Compr Physiol. 2013;3:1473-1492. [PMID: 24265236 DOI: 10.1002/cphy.c120035] [Cited by in Crossref: 347] [Cited by in F6Publishing: 342] [Article Influence: 49.6] [Reference Citation Analysis]
35 Carman AJ, Mills JH, Krenz A, Kim DG, Bynoe MS. Adenosine receptor signaling modulates permeability of the blood-brain barrier. J Neurosci 2011;31:13272-80. [PMID: 21917810 DOI: 10.1523/JNEUROSCI.3337-11.2011] [Cited by in Crossref: 161] [Cited by in F6Publishing: 95] [Article Influence: 16.1] [Reference Citation Analysis]
36 Yang Y, Wang H, Lv X, Wang Q, Zhao H, Yang F, Yang Y, Li J. Involvement of cAMP-PKA pathway in adenosine A1 and A2A receptor-mediated regulation of acetaldehyde-induced activation of HSCs. Biochimie 2015;115:59-70. [DOI: 10.1016/j.biochi.2015.04.019] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
37 Li S, Wang Q, Tao Y, Liu C. Swertiamarin Attenuates Experimental Rat Hepatic Fibrosis by Suppressing Angiotensin II–Angiotensin Type 1 Receptor–Extracellular Signal-Regulated Kinase Signaling. J Pharmacol Exp Ther 2016;359:247-55. [DOI: 10.1124/jpet.116.234179] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
38 Li S, Zhao W, Zhao Z, Cheng B, Li S, Liu C. Levistilide A reverses rat hepatic fibrosis by suppressing angiotensin II‑induced hepatic stellate cells activation. Mol Med Rep 2020;22:2191-8. [PMID: 32705207 DOI: 10.3892/mmr.2020.11326] [Reference Citation Analysis]
39 Moeller M, Thonig A, Pohl S, Ripoll C, Zipprich A. Hepatic arterial vasodilation is independent of portal hypertension in early stages of cirrhosis. PLoS One. 2015;10:e0121229. [PMID: 25793622 DOI: 10.1371/journal.pone.0121229] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
40 Velasco-Loyden G, Pérez-Carreón JI, Agüero JF, Romero PC, Vidrio-Gómez S, Martínez-Pérez L, Yáñez-Maldonado L, Hernández-Muñoz R, Macías-Silva M, de Sánchez VC. Prevention of in vitro hepatic stellate cells activation by the adenosine derivative compound IFC305. Biochem Pharmacol 2010;80:1690-9. [PMID: 20813095 DOI: 10.1016/j.bcp.2010.08.017] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
41 Xu W, Lu C, Zhang F, Shao J, Zheng S. Dihydroartemisinin restricts hepatic stellate cell contraction via an FXR-S1PR2-dependent mechanism: Dihydroartemisinin Restricts HSC Contraction. IUBMB Life 2016;68:376-87. [DOI: 10.1002/iub.1492] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 4.6] [Reference Citation Analysis]
42 Cummins KA, Crampton AL, Wood DK. A High-Throughput Workflow to Study Remodeling of Extracellular Matrix-Based Microtissues. Tissue Eng Part C Methods 2019;25:25-36. [PMID: 30430922 DOI: 10.1089/ten.TEC.2018.0290] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
43 Elpek G&. Cellular and molecular mechanisms in the pathogenesis of liver fibrosis: An update. World J Gastroenterol 2014; 20(23): 7260-7276 [PMID: 24966597 DOI: 10.3748/wjg.v20.i23.7260] [Cited by in CrossRef: 173] [Cited by in F6Publishing: 154] [Article Influence: 24.7] [Reference Citation Analysis]
44 Gill US, Zissimopoulos A, Al-Shamma S, Burke K, McPhail MJ, Barr DA, Kallis YN, Marley RT, Kooner P, Foster GR. Assessment of bone mineral density in tenofovir-treated patients with chronic hepatitis B: can the fracture risk assessment tool identify those at greatest risk? J Infect Dis. 2015;211:374-382. [PMID: 25156561 DOI: 10.1093/infdis/jiu471] [Cited by in Crossref: 50] [Cited by in F6Publishing: 44] [Article Influence: 7.1] [Reference Citation Analysis]
45 Xiao H, Si LY, Liu W, Li N, Meng G, Yang N, Chen X, Zhou YG, Shen HY. The effects of adenosine A2A receptor knockout on renal interstitial fibrosis in a mouse model of unilateral ureteral obstruction. Acta Histochem 2013;115:315-9. [PMID: 23026406 DOI: 10.1016/j.acthis.2012.09.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
46 de Oliveira CM, Martins LAM, de Sousa AC, Moraes KDS, Costa BP, Vieira MQ, Coelho BP, Borojevic R, de Oliveira JR, Guma FCR. Resveratrol increases the activation markers and changes the release of inflammatory cytokines of hepatic stellate cells. Mol Cell Biochem 2021;476:649-61. [PMID: 33073314 DOI: 10.1007/s11010-020-03933-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
47 Cunha RA. How does adenosine control neuronal dysfunction and neurodegeneration? J Neurochem 2016;139:1019-55. [PMID: 27365148 DOI: 10.1111/jnc.13724] [Cited by in Crossref: 201] [Cited by in F6Publishing: 188] [Article Influence: 40.2] [Reference Citation Analysis]
48 Schachtrup C, Le Moan N, Passino MA, Akassoglou K. Hepatic stellate cells and astrocytes: Stars of scar formation and tissue repair. Cell Cycle. 2011;10:1764-1771. [PMID: 21555919 DOI: 10.4161/cc.10.11.15828] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 2.0] [Reference Citation Analysis]
49 Shimada H, Staten NR, Rajagopalan LE. TGF-β1 mediated activation of Rho kinase induces TGF-β2 and endothelin-1 expression in human hepatic stellate cells. J Hepatol. 2011;54:521-528. [PMID: 21087804 DOI: 10.1016/j.jhep.2010.07.026] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 3.1] [Reference Citation Analysis]
50 Yamaguchi M, Dohi N, Ooka A, Saito SY, Ishikawa T. Caffeine-induced inversion of prostaglandin E2 effects on hepatic stellate cell activation. Biomed Pharmacother 2021;142:111989. [PMID: 34388524 DOI: 10.1016/j.biopha.2021.111989] [Reference Citation Analysis]
51 Kuroda S, Tashiro H, Igarashi Y, Tanimoto Y, Nambu J, Oshita A, Kobayashi T, Amano H, Tanaka Y, Ohdan H. Rho inhibitor prevents ischemia-reperfusion injury in rat steatotic liver. J Hepatol 2012;56:146-52. [PMID: 21756846 DOI: 10.1016/j.jhep.2011.04.029] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
52 Machado SR, Parise ER, de Carvalho L. Coffee has hepatoprotective benefits in Brazilian patients with chronic hepatitis C even in lower daily consumption than in American and European populations. The Brazilian Journal of Infectious Diseases 2014;18:170-6. [DOI: 10.1016/j.bjid.2013.09.001] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
53 Xiao H, Shen HY, Liu W, Xiong RP, Li P, Meng G, Yang N, Chen X, Si LY, Zhou YG. Adenosine A2A receptor: a target for regulating renal interstitial fibrosis in obstructive nephropathy. PLoS One 2013;8:e60173. [PMID: 23585831 DOI: 10.1371/journal.pone.0060173] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
54 Fausther M. Extracellular adenosine: a critical signal in liver fibrosis. American Journal of Physiology-Gastrointestinal and Liver Physiology 2018;315:G12-9. [DOI: 10.1152/ajpgi.00006.2018] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
55 Eubanks HB, Lavoie EG, Goree J, Kamykowski JA, Gokden N, Fausther M, Dranoff JA. Reduction in SNAP-23 Alters Microfilament Organization in Myofibrobastic Hepatic Stellate Cells. Gene Expr 2020;20:25-37. [PMID: 31757226 DOI: 10.3727/105221619X15742818049365] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
56 Wang P, Jia J, Zhang D. Purinergic signalling in liver diseases: Pathological functions and therapeutic opportunities. JHEP Rep 2020;2:100165. [PMID: 33103092 DOI: 10.1016/j.jhepr.2020.100165] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
57 Zhang F, Wang F, He J, Lian N, Wang Z, Shao J, Ding H, Tan S, Chen A, Zhang Z, Wang S, Zheng S. Regulation of hepatic stellate cell contraction and cirrhotic portal hypertension by Wnt/β-catenin signalling via interaction with Gli1. Br J Pharmacol 2021;178:2246-65. [PMID: 33085791 DOI: 10.1111/bph.15289] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]